findmyKOL

Roger Rodby, MD

Basic profile

Rush University Medical Center

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Roger Rodby is a Nephrology physician affiliated with Rush University Medical Center. OpenAlex indexes 137 publications with 5,427 citations (h-index 33).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
137publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,427citations

Total citations across indexed works.

33h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1426 W Washington Blvd
Chicago, IL 606071821

Telephone

312-829-1424

Registry record last updated 25 Sept 2012.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.5%
    Angiotensin receptor blocker (ARB)41.4%
    Losartan Potassium62%Irbesartan38%
    Part D<11 patients
    Loop diuretic9.1%
    Furosemide100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    36.6%
    SGLT2 inhibitor18.3%
    Jardiance68%Farxiga32%
    Part D<11 patients
    Metabolic Alkalinizer10.8%
    Potassium Citrate Er100%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    7%
    Purine Antimetabolite7%
    Azathioprine100%
    Part D<11 patients
Where care is delivered (Part B)57% facility · 43% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”